What Dispensaries Need to Know About Schedule III Cannabis
On April 23, 2026, the DOJ made it official: cannabis products regulated under a qualifying state medical marijuana license, plus FDA-approved cannabis drug products, are now Schedule III under the Controlled Substances Act. Legal experts and industry analysts are calling it the most significant federal cannabis action in decades.
But the details matter enormously depending on how your business is licensed. Here's what changed, what didn't, and what to do about it.
In This Post
- What the April 23 Schedule III ruling actually means
- How rescheduling happened and why it moved fast
- What's next: the June 29 DEA hearing
- Why 280E hits dispensaries so hard
- Banking is still a bottleneck (reschedule or not)
- Why dispensary economics are tough, regardless
- Practical next steps for operators
What the April 23 Schedule III Ruling Means for Your Dispensary
The ruling is split. Where you land depends entirely on your license type.
If you hold a state medical marijuana license
280E likely no longer applies to your medical cannabis operations. That means you may finally be able to deduct ordinary business expenses like rent, payroll, marketing, and your point of sale software, the same way any other legal business does. For medical-licensed operations, this could provide immediate margin and cash-flow relief.
One important caveat: Treasury guidance on expense allocation is still pending. If you hold both a medical and adult-use license, expect complex accounting questions around how you allocate shared costs like rent and payroll between the two operations. Talk to your CPA now, not at year-end.
If you're adult-use only
Nothing changed for you on April 23. If you're operating rec-only in California, Michigan, New York, or any other adult-use market, 280E still applies to your business in full. The relief you've been waiting for is still in play, but it's not here yet.
How Rescheduling Happened and Why It Moved Fast
Acting AG Blanche used a treaty-based legal pathway under 21 U.S.C. § 811(d)(1), tied to U.S. obligations under the U.N. Single Convention on Narcotic Drugs. This route let the DOJ bypass the lengthy notice-and-comment rulemaking process that had been grinding along since the Biden administration's proposed rule hit the Federal Register in May 2024. That prior process has been formally withdrawn and replaced with an expedited hearing.
One operational nuance worth knowing: to satisfy Single Convention treaty requirements, the DEA becomes the nominal wholesaler for licensed medical cultivators. Cultivators technically sell their crop to DEA at a nominal price and buy it back with an administrative fee.
What's Next: The June 29 DEA Hearing
April 23 was a partial step. Whether adult-use cannabis gets rescheduled to Schedule III is still unresolved, and June 29, 2026 is the date that matters next.
DEA has announced a new administrative hearing beginning June 29 to consider broader rescheduling of all cannabis, not just medical. The prior Biden-era proceedings have been scrapped and replaced with this expedited process, which includes firm deadlines designed to move faster than the years-long stall the industry has been watching.
For adult-use operators: stay informed, mark June 29, but don't restructure your business around an outcome that isn't final yet.
Why 280E Hits Dispensaries So Hard
For operators new to the conversation, here's why this matters so much.
IRS Code Section 280E prevents Schedule I and II cannabis businesses from deducting most ordinary business expenses on federal taxes. You pay tax on gross profit rather than net, leaving some effective tax rates well north of 50% for legal operators. Unlike a typical retailer, you can't write off rent, payroll, or even office supplies.
When 280E goes away, dispensaries can finally deduct normal expenses like any other business, including marketing, software, and operational costs. The impact on margins is significant. One industry expert called it "immediate margin and cash-flow relief" and "the difference between survival and investment" for plant-touching companies (source: mjbizdaily.com).
This chart from Headset shows how Section 280E impacts the typical cannabis retailer's net profit across multiple U.S. markets. In several states, the 280E tax burden exceeds net profit entirely. For adult-use operators, this is still the reality post-April 23.
Banking Remains a Bottleneck (Reschedule or Not)
If you're hoping rescheduling will solve the other massive headache of banking and payments, here's a reality check: it won't, at least not by itself.
Banks and credit unions still face federal risks servicing our industry as long as cannabis is controlled at all. Schedule III is a lower category, but it's still controlled.
For years, the SAFE Banking Act (now the SAFER Banking Act) has dangled the hope of fixing this. As of April 2026, it's still not law. It's been proposed, debated, even passed in some form multiple times, but never fully enacted.
Without a specific safe harbor in federal law, most banks will remain very cautious about cannabis accounts. Many operators are forced to either operate mostly in cash or use workarounds and pay high fees to the few financial institutions willing to take the risk. This isn't just inconvenient. Cash-heavy operations are security risks and add expensive measures for safekeeping daily cash drops.
True banking relief likely requires Congress to act. Rescheduling may encourage more banks to explore cannabis clients, but meaningful change, like access to loans, credit card processing, and normal business banking, depends on legislation that explicitly shields banks. With Schedule III now in motion for medical, pressure should mount in 2026 to finally pass banking reform.
Why the Economics of Running a Dispensary Are Tough
Even with rescheduling underway, the math of running a cannabis retail business is challenging. A few realities shape the landscape:
- Heavy tax burden. State excise taxes, local cannabis business taxes, and additional fees stack on top of federal 280E exposure for adult-use operators.
- Compliance costs. Licensing, seed-to-sale tracking, security requirements, lab testing, and packaging rules raise the cost of doing business.
- Pricing pressure. In mature markets, prices are falling. Competing on price alone isn't sustainable without major scale or efficiency advantages.
- Illicit market competition. Underground sellers skip every cost above, which is why differentiation matters more than discounting.
- Limited financing. Traditional lending is largely closed off, so most operators rely on private capital or their own cash to grow.
Roughly 27% of dispensaries are profitable today. The operators holding their ground are the ones running tight, efficient operations and building real customer loyalty.
Practical Tips and Next Steps
How do you plan when the rules might change but you have to survive right now?
Talk to your CPA now. This is the single most important move post-April 23. Understand exactly how your licenses are structured, how you allocate COGS today, and what changes if 280E relief expands. If you hold both medical and adult-use licenses, get ahead of the shared-cost allocation question.
Get your books clean. If 280E relief expands to adult-use later this year, the dispensaries that are prepared will move fastest. Meticulous bookkeeping isn't optional anymore. It's the foundation for capitalizing on whatever comes next.
Optimize for efficiency. Every percentage point counts. Streamline operations, refine staff schedules, negotiate better terms with suppliers, and adopt technology that automates manual tasks. A POS system that integrates seamlessly with compliance tracking saves hours of admin work, hours better spent on sales and customer experience.
Differentiate beyond price. Loyal customers stick with operators who deliver value beyond a few dollars saved. Curated product selection, fast delivery, knowledgeable budtenders, a strong loyalty program. Give customers reasons to choose you that aren't on the price tag.
Take care of your team. Turnover is expensive. A motivated, well-informed team keeps customers happy and operations smooth, even when margins are thin.
Stay informed, but don't operate on rumors. Watch for Treasury guidance on expense allocation. Mark June 29 for the DEA hearing on broader rescheduling. Keep an eye on banking reform momentum. Plan for relief, but continue to run your business efficiently under current conditions.
Closing Thoughts
Change is no longer just coming. It's arriving, unevenly, and on a complicated timeline.
If you're a medical operator, this week marked a genuine turning point. If you're adult-use, you're watching from the sideline for now, but the timeline is shorter than it's been in years.
Either way, the move to make right now is the same: talk to your CPA, understand exactly how your licenses are structured, and make sure your books are clean. If 280E relief expands to adult-use operations later this year, the dispensaries that are prepared will move fastest.
We'll keep covering this as it develops. In the meantime, Meadow is here to help you run a tighter, more profitable operation regardless of what Washington does next.
